<Record>
<Term>Perindopril Erbumine</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<SemanticType>Organic Chemical</SemanticType>
<ParentTerm>ACE Inhibitor</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Enzyme Inhibitor/ACE Inhibitor/Perindopril Erbumine</ClassificationPath>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Enzyme Inhibitor</BroaderTerm>
<BroaderTerm>Perindopril Erbumine</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>ACE Inhibitor</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>Perindopril erbumine</Synonym>
<Synonym>PERINDOPRIL ERBUMINE</Synonym>
<Synonym>1H-Indole-2-carboxylic Acid, 1-(2-((1-(ethoxycarbonyl)butyl)amino)-1-oxopropyl)octahydro-,(2S-(1(R*(R*))2alpha,3abeta,7abeta))-, compound with 2-Methyl-2-propanamine(1:1)</Synonym>
<Synonym>Perindopril Erbumine</Synonym>
<Synonym>Aceon</Synonym>
<Description>The tert-butylamine salt of perindopril, the ethyl ester of a non-sulfhydryl angiotensin converting enzyme (ACE) inhibitor with antihypertensive property. Upon hydrolysis, perindopril erbumine is converted to its active form perindoprilat, which inhibits ACE, thereby blocks the conversion of angiotensin I to angiotensin II. This prevents angiotensin II-mediated vasoconstriction, decreases angiotensin II-stimulated aldosterone secretion from the adrenal cortex, and consequently promotes diuresis and natriuresis.</Description>
<Source>FDA Registry</Source>
<Source>NCI Thesaurus</Source>
</Record>
